Theraclion

About Theraclion

A French MedTech company specializing in non-invasive focused ultrasound therapy as an alternative to surgery for varicose veins, breast fibroadenoma, and thyroid nodules

Key facts

Industry

Medical Equipment Manufacturing

Company size

11–50 employees

Headquarters

Malakoff, Île-de-France, France

Founded

2004

Revenue

$9M – $51.1MTamtam estimate

SIREN

478129968

Website

theraclion.com

LinkedIn

linkedin.com/company/theraclion

Theraclion in the news

• Theraclion : l'horizon de trésorerie s'étend à août 2026...

  Theraclion's revenue grew significantly in H1 2025 with reduced net loss and cash runway extended to August 2026, supporting ongoing development and research.

  bourse.fortuneo.fr · Oct 31, 2025
• Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results

  Theraclion advanced regulatory approvals and commercial rollout of its non-invasive Sonovein® HIFU varicose vein treatment, boosting revenue and reducing losses in H1 2025.

  businesswire.com · Oct 30, 2025
• Theraclion : l'horizon de trésorerie s'étend à août 2026...

  Theraclion's revenue grew significantly in H1 2025 with reduced net loss and cash runway extended to August 2026, supporting ongoing R&D and commercial efforts.

  bourse.fortuneo.fr · Oct 30, 2025
• Theraclion : l'horizon de trésorerie s'étend à août 2026

  Theraclion's revenue grew significantly in H1 2025 with reduced net loss and cash runway extended to August 2026, supporting ongoing development and research.

  boursier.com · Oct 29, 2025
• Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results

  Theraclion reported strong clinical results, regulatory certifications in Europe and China, significant revenue growth, and plans for U.S. market entry in 2026.

  finance.yahoo.com · Oct 29, 2025